81.1 USD
+2.27 (+2.88%)
81.1 USD
0 (0%)
Taking everything into account, GEHC scores 5 out of 10 in our fundamental rating. GEHC was compared to 186 industry peers in the Health Care Equipment & Supplies industry. While GEHC belongs to the best of the industry regarding profitability, there are concerns on its financial health. GEHC is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
- In the past year GEHC was profitable.
- GEHC had a positive operating cash flow in the past year.
- In the past 5 years GEHC has always been profitable.
- In the past 5 years GEHC always reported a positive cash flow from operatings.
1.2 Ratios
- GEHC's Return On Assets of 6.14% is amongst the best of the industry. GEHC outperforms 84.41% of its industry peers.
- GEHC has a better Return On Equity (22.19%) than 95.16% of its industry peers.
- GEHC has a better Return On Invested Capital (7.77%) than 83.87% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for GEHC is in line with the industry average of 8.84%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.14% | ||
| ROE | 22.19% | ||
| ROIC | 7.77% |
ROA(3y)5.75%
ROA(5y)16.59%
ROE(3y)21.16%
ROE(5y)34.2%
ROIC(3y)8.36%
ROIC(5y)9.41%
1.3 Margins
- Looking at the Profit Margin, with a value of 10.95%, GEHC belongs to the top of the industry, outperforming 84.95% of the companies in the same industry.
- GEHC's Profit Margin has improved in the last couple of years.
- Looking at the Operating Margin, with a value of 13.52%, GEHC belongs to the top of the industry, outperforming 81.72% of the companies in the same industry.
- In the last couple of years the Operating Margin of GEHC has remained more or less at the same level.
- GEHC has a Gross Margin of 40.80%. This is in the lower half of the industry: GEHC underperforms 67.20% of its industry peers.
- GEHC's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.52% | ||
| PM (TTM) | 10.95% | ||
| GM | 40.8% |
OM growth 3Y-5.66%
OM growth 5Y0.88%
PM growth 3Y-7.45%
PM growth 5Y2.03%
GM growth 3Y0.74%
GM growth 5Y1.16%
2. Health
2.1 Basic Checks
- GEHC has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- Compared to 1 year ago, GEHC has more shares outstanding
- GEHC has a better debt/assets ratio than last year.
2.2 Solvency
- GEHC has an Altman-Z score of 1.88. This is not the best score and indicates that GEHC is in the grey zone with still only limited risk for bankruptcy at the moment.
- With a Altman-Z score value of 1.88, GEHC perfoms like the industry average, outperforming 57.53% of the companies in the same industry.
- The Debt to FCF ratio of GEHC is 7.38, which is on the high side as it means it would take GEHC, 7.38 years of fcf income to pay off all of its debts.
- With a decent Debt to FCF ratio value of 7.38, GEHC is doing good in the industry, outperforming 74.73% of the companies in the same industry.
- GEHC has a Debt/Equity ratio of 0.83. This is a neutral value indicating GEHC is somewhat dependend on debt financing.
- GEHC has a worse Debt to Equity ratio (0.83) than 72.58% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.83 | ||
| Debt/FCF | 7.38 | ||
| Altman-Z | 1.88 |
ROIC/WACC0.8
WACC9.77%
2.3 Liquidity
- A Current Ratio of 1.18 indicates that GEHC should not have too much problems paying its short term obligations.
- With a Current ratio value of 1.18, GEHC is not doing good in the industry: 81.18% of the companies in the same industry are doing better.
- A Quick Ratio of 0.95 indicates that GEHC may have some problems paying its short term obligations.
- GEHC has a worse Quick ratio (0.95) than 77.96% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.18 | ||
| Quick Ratio | 0.95 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an nice 8.77% over the past year.
- The Earnings Per Share has been growing slightly by 5.32% on average over the past years.
- GEHC shows a small growth in Revenue. In the last year, the Revenue has grown by 3.52%.
- Measured over the past years, GEHC shows a small growth in Revenue. The Revenue has been growing by 3.41% on average per year.
EPS 1Y (TTM)8.77%
EPS 3Y-4.21%
EPS 5Y5.32%
EPS Q2Q%-6.14%
Revenue 1Y (TTM)3.52%
Revenue growth 3Y3.81%
Revenue growth 5Y3.41%
Sales Q2Q%5.76%
3.2 Future
- The Earnings Per Share is expected to grow by 7.54% on average over the next years.
- The Revenue is expected to grow by 3.87% on average over the next years.
EPS Next Y3.45%
EPS Next 2Y5.89%
EPS Next 3Y7.69%
EPS Next 5Y7.54%
Revenue Next Year4.16%
Revenue Next 2Y4.24%
Revenue Next 3Y4.32%
Revenue Next 5Y3.87%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 17.67, GEHC is valued on the expensive side.
- Based on the Price/Earnings ratio, GEHC is valued cheaper than 86.02% of the companies in the same industry.
- When comparing the Price/Earnings ratio of GEHC to the average of the S&P500 Index (27.32), we can say GEHC is valued slightly cheaper.
- A Price/Forward Earnings ratio of 16.11 indicates a correct valuation of GEHC.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of GEHC indicates a rather cheap valuation: GEHC is cheaper than 87.63% of the companies listed in the same industry.
- The average S&P500 Price/Forward Earnings ratio is at 24.30. GEHC is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.67 | ||
| Fwd PE | 16.11 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, GEHC is valued cheaper than 86.02% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, GEHC is valued cheaply inside the industry as 83.87% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 26.39 | ||
| EV/EBITDA | 12.76 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates GEHC does not grow enough to justify the current Price/Earnings ratio.
- The decent profitability rating of GEHC may justify a higher PE ratio.
PEG (NY)5.12
PEG (5Y)3.32
EPS Next 2Y5.89%
EPS Next 3Y7.69%
5. Dividend
5.1 Amount
- With a yearly dividend of 0.17%, GEHC is not a good candidate for dividend investing.
- GEHC's Dividend Yield is rather good when compared to the industry average which is at 0.19. GEHC pays more dividend than 89.78% of the companies in the same industry.
- With a Dividend Yield of 0.17, GEHC pays less dividend than the S&P500 average, which is at 1.86.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.17% |
5.2 History
- GEHC has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
5.3 Sustainability
- GEHC pays out 2.80% of its income as dividend. This is a sustainable payout ratio.
DP2.8%
EPS Next 2Y5.89%
EPS Next 3Y7.69%
81.1
+2.27 (+2.88%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-29 2025-10-29/bmo
Earnings (Next)02-04 2026-02-04/bmo
Inst Owners89.01%
Inst Owner Change0.22%
Ins Owners0.28%
Ins Owner Change-0.04%
Market Cap36.94B
Revenue(TTM)20.25B
Net Income(TTM)2.22B
Analysts79.29
Price Target93.55 (15.35%)
Short Float %2.47%
Short Ratio3.17
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.17% |
Yearly Dividend0.12
Dividend Growth(5Y)N/A
DP2.8%
Div Incr Years1
Div Non Decr Years1
Ex-Date01-09 2026-01-09 (0.035)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)6.54%
Min EPS beat(2)-0.16%
Max EPS beat(2)13.24%
EPS beat(4)3
Avg EPS beat(4)8.5%
Min EPS beat(4)-0.16%
Max EPS beat(4)13.24%
EPS beat(8)6
Avg EPS beat(8)5.72%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.92%
Min Revenue beat(2)-1.09%
Max Revenue beat(2)-0.75%
Revenue beat(4)1
Avg Revenue beat(4)-0.9%
Min Revenue beat(4)-2.17%
Max Revenue beat(4)0.42%
Revenue beat(8)2
Avg Revenue beat(8)-1.64%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.44%
PT rev (3m)4.73%
EPS NQ rev (1m)0.82%
EPS NQ rev (3m)0.26%
EPS NY rev (1m)0.82%
EPS NY rev (3m)0.76%
Revenue NQ rev (1m)0.03%
Revenue NQ rev (3m)-0.14%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.28%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.67 | ||
| Fwd PE | 16.11 | ||
| P/S | 1.82 | ||
| P/FCF | 26.39 | ||
| P/OCF | 19.97 | ||
| P/B | 3.7 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.76 |
EPS(TTM)4.59
EY5.66%
EPS(NY)5.03
Fwd EY6.21%
FCF(TTM)3.07
FCFY3.79%
OCF(TTM)4.06
OCFY5.01%
SpS44.45
BVpS21.94
TBVpS-10.12
PEG (NY)5.12
PEG (5Y)3.32
Graham Number47.6
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.14% | ||
| ROE | 22.19% | ||
| ROCE | 10.51% | ||
| ROIC | 7.77% | ||
| ROICexc | 9.18% | ||
| ROICexgc | 27.2% | ||
| OM | 13.52% | ||
| PM (TTM) | 10.95% | ||
| GM | 40.8% | ||
| FCFM | 6.91% |
ROA(3y)5.75%
ROA(5y)16.59%
ROE(3y)21.16%
ROE(5y)34.2%
ROIC(3y)8.36%
ROIC(5y)9.41%
ROICexc(3y)9.28%
ROICexc(5y)10.16%
ROICexgc(3y)32.48%
ROICexgc(5y)41.69%
ROCE(3y)11.31%
ROCE(5y)12.72%
ROICexgc growth 3Y-14.77%
ROICexgc growth 5YN/A
ROICexc growth 3Y-4.79%
ROICexc growth 5YN/A
OM growth 3Y-5.66%
OM growth 5Y0.88%
PM growth 3Y-7.45%
PM growth 5Y2.03%
GM growth 3Y0.74%
GM growth 5Y1.16%
F-Score5
Asset Turnover0.56
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.83 | ||
| Debt/FCF | 7.38 | ||
| Debt/EBITDA | 2.51 | ||
| Cap/Depr | 78.67% | ||
| Cap/Sales | 2.22% | ||
| Interest Coverage | 5.09 | ||
| Cash Conversion | 55.91% | ||
| Profit Quality | 63.15% | ||
| Current Ratio | 1.18 | ||
| Quick Ratio | 0.95 | ||
| Altman-Z | 1.88 |
F-Score5
WACC9.77%
ROIC/WACC0.8
Cap/Depr(3y)60.52%
Cap/Depr(5y)52.47%
Cap/Sales(3y)1.9%
Cap/Sales(5y)1.73%
Profit Quality(3y)98.54%
Profit Quality(5y)74.63%
High Growth Momentum
Growth
EPS 1Y (TTM)8.77%
EPS 3Y-4.21%
EPS 5Y5.32%
EPS Q2Q%-6.14%
EPS Next Y3.45%
EPS Next 2Y5.89%
EPS Next 3Y7.69%
EPS Next 5Y7.54%
Revenue 1Y (TTM)3.52%
Revenue growth 3Y3.81%
Revenue growth 5Y3.41%
Sales Q2Q%5.76%
Revenue Next Year4.16%
Revenue Next 2Y4.24%
Revenue Next 3Y4.32%
Revenue Next 5Y3.87%
EBIT growth 1Y8.91%
EBIT growth 3Y-2.07%
EBIT growth 5Y4.33%
EBIT Next Year18.28%
EBIT Next 3Y10.99%
EBIT Next 5Y9.55%
FCF growth 1Y-18.75%
FCF growth 3Y4.48%
FCF growth 5Y0.56%
OCF growth 1Y-11.61%
OCF growth 3Y6.68%
OCF growth 5Y1.2%
GE HEALTHCARE TECHNOLOGY / GEHC FAQ
What is the fundamental rating for GEHC stock?
ChartMill assigns a fundamental rating of 5 / 10 to GEHC.
What is the valuation status for GEHC stock?
ChartMill assigns a valuation rating of 6 / 10 to GE HEALTHCARE TECHNOLOGY (GEHC). This can be considered as Fairly Valued.
How profitable is GE HEALTHCARE TECHNOLOGY (GEHC) stock?
GE HEALTHCARE TECHNOLOGY (GEHC) has a profitability rating of 7 / 10.
What is the financial health of GE HEALTHCARE TECHNOLOGY (GEHC) stock?
The financial health rating of GE HEALTHCARE TECHNOLOGY (GEHC) is 3 / 10.
Can you provide the dividend sustainability for GEHC stock?
The dividend rating of GE HEALTHCARE TECHNOLOGY (GEHC) is 3 / 10 and the dividend payout ratio is 2.8%.